Company Profile
Updated: 06-NOV-09Innogenetics S.A./NV
Non-Quoted Public Company
Technologiepark 6, Gent, B-9052, Belgium
()32 09 329 13 29, 32 09 329 19 11 fax, http://www.innogenetics.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Development and marketing of diagnostic products for the detection of human diseases, as well as the discovery and development of new therapeutic products and vaccines in the following areas: infectious diseases, genetic testing, transplantation, neurodegeneration and oncology
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Belgian Biotech Growth Owes Much To Flanders.
BIOWORLD Today; 11/3/2009; 1316 words; ...Techologiepark include Innogenetics NV, a long-tenured firm...and Bayer BioScience NV, the agricultural biotech...Plant Genetics Systems NV before being absorbed...and then Bayer. While Innogenetics recently reported a setback...quarter the company's shares, which trade on...
Two IPOs Highlight Recent Flemish Financing Activities.
BIOWORLD Today; 11/3/2009; 1342 words; ...Dutch company, Crucell NV. Those companies initially...time." Among Belgium's established public biotech...companies is one of its oldest, Innogenetics NV, which has a market capitalization...diseases. Also among Belgium's public biotech companies...
The Top 40 Manufacturers In Europe Of In Vitro Diagnostics For Infectious Diseases.
M2 Presswire; 9/9/2009; 1280 words; ...DiaMed Holding AG - Diasorin S.p.A. - DIESSE Diagnostica Senese S.p.A. - Enigma Diagnostics...Laboratories - Genomica - Grifols, S.A. - Human GmbH - HYCOR - IBL International GmbH - Innogenetics NV - Institute Virion\Serion...
New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report.
PR Newswire; 7/7/2009; 3199 words; ...Idenix Pharmaceuticals, Inc., Innogenetics NV, InterMune, Inc., Intarcia Therapeutics...Stage II-6 SCH 900518 - Schering's Next-Generation Protease Inhibitor...Inhibitor II-6 Boceprevir - Schering's PI Class Lead Candidate II-7 Comparison...
Reportlinker Adds World Hepatitis C Virus and Therapeutics Market Report.
Business Wire; 5/18/2009; 3619 words; ...Idenix Pharmaceuticals, Inc., Innogenetics NV, InterMune, Inc., Intarcia Therapeutics...Stage II-6 SCH 900518 - Schering's Next-Generation Protease Inhibitor...Inhibitor II-6 Boceprevir - Schering's PI Class Lead Candidate II-7 Comparison...
Recent News Articles
- Innogenetics NV - Financial and Strategic Analysis Review.
M2 Presswire - April 30, 2009 - Innogenetics NV-Company Report.
M2 Presswire - February 05, 2009 - Full Year 2007 Innogenetics NV Earnings Conference Call - Final.
Fair Disclosure Wire - February 29, 2008 - Q3 2007 Innogenetics NV Earnings Conference Call - Final.
Fair Disclosure Wire - November 15, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
